| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 09/22/2022 | Eton Pharmaceuticals, Inc. | ETON | Purchase | Common Stock | 10k | $2.10 | $21k | | 09/22/2022 |
| 07/12/2022 | Eton Pharmaceuticals, Inc. | ETON | Grant | Restricted Stock Units | 110k | $0.00 | $0 | | 07/12/2022 |
| 02/07/2022 | Eton Pharmaceuticals, Inc. | ETON | Grant | Stock Option(Right to buy) | 416.5k | $3.78 | $1.6M | | 02/07/2022 |
| 08/20/2021 | Eton Pharmaceuticals, Inc. | ETON | Purchase | Common Stock | 10k | $4.32 | $43.2k | | 08/20/2021 |
| 06/03/2021 | Eton Pharmaceuticals, Inc. | ETON | Purchase | Common Stock | 5k | $5.96 | $29.8k | | 06/03/2021 |
| 05/03/2021 | Eton Pharmaceuticals, Inc. | ETON | Grant | Stock Option(Right to buy) | 245k | $8.61 | $2.1M | | 05/03/2021 |
| 03/12/2020 | Eton Pharmaceuticals, Inc. | ETON | Grant | Stock Option (Right to buy) | 490k | $3.58 | $1.8M | | 03/12/2020 |
| 08/13/2019 | Eton Pharmaceuticals, Inc. | ETON | Purchase | Common Stock | 5k | $6.15 | $30.8k | | 08/13/2019 |
| 05/21/2019 | Eton Pharmaceuticals, Inc. | ETON | Purchase | Common Stock | 8.6k | $7.96 | $68.4k | | 05/20/2019 |
| 05/20/2019 | Eton Pharmaceuticals, Inc. | ETON | Purchase | Common Stock | 1.4k | $7.78 | $10.9k | | 05/20/2019 |
| 02/20/2019 | Eton Pharmaceuticals, Inc. | ETON | Grant | Stock option (right to buy) | 250k | $7.31 | $1.8M | | 02/20/2019 |
| 11/15/2018 | Eton Pharmaceuticals, Inc. | ETON | Conversion | Series A Convertible Preferred Stock | 23k | $0.00 | $0 | by LLC | 11/15/2018 |
| 11/15/2018 | Eton Pharmaceuticals, Inc. | ETON | Purchase | Common Stock | 10k | $6.00 | $60k | | 11/15/2018 |
| 11/15/2018 | Eton Pharmaceuticals, Inc. | ETON | Conversion | Common Stock | 24.9k | $0.00 | $0 | by LLC | 11/15/2018 |
| 08/29/2016 | Sagent Pharmaceuticals, Inc. | SGNT | Disposition | Stock Option to Buy | 21k | $12.19 | $256.2k | | 08/29/2016 |
| 08/29/2016 | Sagent Pharmaceuticals, Inc. | SGNT | Disposition | Common Stock | 9.8k | $21.75 | $214.1k | | 08/29/2016 |